DNA & Genetics Challenging Pfizer, Novo Nordisk Offers Up-to-$9B for MetseraBy adminOctober 31, 20250 Intent on growing its leading position in obesity and weight management drugs, Novo Nordisk has made an unsolicited, approximately up-to-$9…
